scholarly journals Prognosis of late elderly patients with chronic hepatitis C after achieving a sustained viral response by direct‐acting antivirals

JGH Open ◽  
2020 ◽  
Author(s):  
Satoshi Takakusagi ◽  
Hitoshi Takagi ◽  
Takashi Kosone ◽  
Ken Sato ◽  
Satoru Kakizaki ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Elderly Patients ◽  
Chronic Hepatitis C ◽  
Sustained Viral Response ◽  
Direct Acting Antivirals ◽  
Viral Response ◽  
Direct Acting

scholarly journals Korszakváltás a krónikus C-vírus hepatitis terápiájában – új direkt ható antivirális szerek

2015 ◽  
Vol 156 (21) ◽  
pp. 841-848
Author(s):  
Gábor Horváth ◽  
Tünde Halász ◽  
Mihály Makara ◽  
Béla Hunyady
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Sustained Viral Response ◽  
Virus Hepatitis ◽  
Direct Acting Antivirals ◽  
Screening Programs ◽  
Viral Response ◽  
Direct Acting

Chronic hepatitis C, without treatment, can cause liver cirrhosis, liver failure and liver cancer. The availability of new oral direct acting antivirals, such as the protease inhibitors simeprevir, asunaprevir and paritaprevir, the NS5A inhibitors daclatasvir, ledipasvir, and ombitasvir, the polymerase inhibitors Sofosbuvir and dasabuvir have resulted an enormous progress in the treatment of chronic hepatitis C, leading to >90% sustained viral response rates. Even the hard-to-treat or previously treatment ineligible patients can be cured with the combination of these drugs. Furthermore the treatment duration is much shorter, and the side effects are minimal. Today, treatment of all hepatitis C virus infected patients is recommended, and the best choices are the interferon-free options. Eradication of hepatitis C virus has become realistic, however, appropriate screening programs are mandatory to achieve this goal. Orv. Hetil., 2015, 156(21), 841–848.

scholarly journals Liver-related events and mortality among elderly patients with advanced chronic hepatitis C treated with direct-acting antivirals

PLoS ONE ◽  
2019 ◽  
Vol 14 (6) ◽  
pp. e0217052 ◽  
Author(s):  
Iria Rodríguez-Osorio ◽  
Alvaro Mena ◽  
Héctor Meijide ◽  
Luis Morano ◽  
Manuel Delgado ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Elderly Patients ◽  
Chronic Hepatitis C ◽  
Direct Acting Antivirals ◽  
Direct Acting

scholarly journals Clinical efficacy and tolerability of direct-acting antivirals in elderly patients with chronic hepatitis C

2017 ◽  
Vol 29 (7) ◽  
pp. 767-776 ◽  
Author(s):  
Jagannath M. Sherigar ◽  
Vijay Gayam ◽  
Arifa Khan ◽  
Osama Mukhtar ◽  
Yavgeniy Arefiev ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Elderly Patients ◽  
Chronic Hepatitis C ◽  
Clinical Efficacy ◽  
Direct Acting Antivirals ◽  
Direct Acting

Direct-acting antivirals combination for elderly patients with chronic hepatitis C: A cost-effectiveness analysis

2017 ◽  
Vol 37 (7) ◽  
pp. 982-994 ◽  
Author(s):  
Antonio Ciaccio ◽  
Paolo A. Cortesi ◽  
Giuseppe Bellelli ◽  
Matteo Rota ◽  
Sara Conti ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Cost Effectiveness ◽  
Hepatitis C ◽  
Elderly Patients ◽  
Chronic Hepatitis C ◽  
Cost Effectiveness Analysis ◽  
Direct Acting Antivirals ◽  
Effectiveness Analysis ◽  
Direct Acting
Sign in / Sign up

Export Citation Format

Share Document